Press "Enter" to skip to content

Rubella Diagnostic Testing Market Size 2019 – Industry Analysis by Types, Applications, Key Players, and leading Countries Forecast to 2024

Rubella Diagnostic Testing

The “Rubella Diagnostic Testing Market” report 2019 provides a comprehensive analysis of Rubella Diagnostic Testing industry by types, applications, key players and regions. It shows the Rubella Diagnostic Testing market 2019-2024 by production, consumption, supply, gross margin, the revenue of the industry. Additionally, the Rubella Diagnostic Testing market report covers the details of market size, share, and growth rate of the market with respect to regions.

Get a Sample Copy of the Report At –

Competitor Analysis:

Rubella Diagnostic Testing market includes the following leading manufacturers on the basis of sales, revenue, price, and gross margin.

  • Abbott
  • Beckman Coulter Inc.
  • Bio Rad Laboratories Inc.
  • Biokit SA
  • bioMérieux SA
  • F. Hoffmann
  • La Roche Ltd
  • Ortho Clinical Diagnostics
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific
  • ZEUS Scientific Inc.

    Market Overview:

  • The major factors for the growth of the rubella diagnostic testing market include the government initiatives to curb the rubella virus, increasing incidences of rubella, and the introduction of advanced point-of-care diagnostic technologies, which are expected to boost the overall growth of the market over the forecast period.
  • There has been an increase in the number of incidences of rubella across the world. Rubella is an acute, contagious viral infection that causes a mild fever and rash illness in children and adults. Infection during pregnancy, especially during the first trimester, can result in miscarriage, stillbirth, fetal death, or infants with congenital malformations. According to the data published by the Centers for Disease Control and Prevention (CDC), rubella is a global health concern, and every year, more than 100,000 cases of congenital rubella syndrome (CRS) are reported, globally. A woman infected with rubella during the first three months of pregnancy has up to a 90% chance of giving birth to a baby with congenital rubella syndrome.
  • In 2015, the WHO Region of the Americas became the first in the world to be declared free of endemic transmission of rubella. Rubella can be prevented with the measles, mumps, and rubella (MMR) vaccine. Governments in various countries across the world are conducting vaccination programs to curb the incidences of rubella. As per the estimates of WHO, as of December 2016, 152 out of 194 countries had introduced rubella vaccines and reported rubella cases declined by 97%, from 670,894 cases in 102 countries, in 2000, to 22,361 cases in 165 countries in 2016.
  • On the other hand, as per the Global Vaccine Action Plan (GVAP) Assessment report, rubella control is lagging, with 42 countries yet to introduce the vaccine.

    Rubella Diagnostic Testing market report presents in-depth analysis regarding the development, current trends, industry policies and regulations implemented in each of the geographical region. It includes analysis of upstream raw materials, downstream demand, and current market dynamics. Furthermore, the Rubella Diagnostic Testing market report provides in-depth insight of Rubella Diagnostic Testing industry during 2019-2024.

    Scope of the Report:

  • As per the , rubella diagnostic testing refers to the detection of the rubella virus. These tests are prescribed for pregnant women and may also be performed on babies born with congenital defects. Rubella can be detected with the help of various diagnostic tests, such as latex agglutination, enzyme immunoassay, radioimmunoassay (RIA), and fluorescent immunoassay (FIA), among others.

    Inquire or Share Your Questions If Any Before the Purchasing This Report –

    Key Market Trends:

    Enzyme Immunoassay Segment under Testing Technique Accounted for the Largest Share in the Global Market

    The detection of rubella-specific immunoglobulin M (IgM) in serum is the standard test for the rapid laboratory diagnosis of rubella. IgM testing is the most commonly performed testing technique using commercial enzyme immunoassay (EIA) kits. The blood test detects antibodies that are made by the immune system to kill the rubella virus, and these antibodies remain in the bloodstream for years. The segment is expected to account for the largest market share, owing to the rising incidences of rubella.

    Asia-Pacific Accounted for the Highest Growth Rate in the Global Market

    The Asia-Pacific segment, by geography, was found to register the fastest growth rate for the rubella diagnostic testing market and is expected to show a similar trend over the forecast period, without significant fluctuations. The Asia-Pacific region holds the highest market share, owing to the presence of larger untapped opportunities, a lack of awareness in some countries, and government initiatives to curb the disease incidence. As per the Global Vaccine Action Plan (GVAP) Assessment report 2017, 42 countries have not yet introduced the vaccine, and two regions, Africa and the Eastern Mediterranean, have not yet set rubella elimination or control targets. Such regions are expected to face high incidences of rubella, which may further drive the growth of the market.

    Reasons to Buy Rubella Diagnostic Testing Market Report:

    • Analysis of Rubella Diagnostic Testing market including revenues, future growth, market outlook
    • Historical data and forecast of Rubella Diagnostic Testing industry
    • Rubella Diagnostic Testing market report covers regional analysis including growth estimates
    • To analyze the end user markets including growth estimates
    • Profiles on laboratory balance including products, sales/revenues, and market position
    • Includes Rubella Diagnostic Testing market structure, market drivers, opportunities, and restraints.

    Purchase this Report (Price 4250 USD for a Single-User License) –

    Rubella Diagnostic Testing Market Report Covers the Following Questions:

    • What trends, challenges and barriers are influencing its growth?
    • What is the and regional outlook for Rubella Diagnostic Testing market?
    • Who are the key players, and what are their strategies?
    • What is the status of Rubella Diagnostic Testing status worldwide?
    • What are the Rubella Diagnostic Testing market challenges to market growth? 
    • What are the Rubella Diagnostic Testing market challenges to market growth? 
    • What are the types and applications of Rubella Diagnostic Testing?
    • What is the market share of each type and application? 

    Detailed TOC of Rubella Diagnostic Testing Market 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Government Initiatives to Curb Rubella Virus
    4.2.2 Increasing Incidences of Rubella
    4.2.3 Introduction of Advance Point-of-care Diagnostic Technologies
    4.3 Market Restraints
    4.3.1 Lack of Awareness among Developing Regions
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5.1 Testing Technique
    5.1.1 Latex Agglutination
    5.1.2 Enzyme Immunoassay (EIA)
    5.1.3 Radioimmunoassay (RIA)
    5.1.4 Fluorescent Immunoassay (FIA)
    5.1.5 Other Testing Techniques
    5.2 Application
    5.2.1 Hospitals
    5.2.2 Laboratories
    5.2.3 Other Applications
    5.3 Geography
    5.3.1 North America US Canada Mexico
    5.3.2 Europe Germany UK France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Abbott
    6.1.2 Beckman Coulter Inc.
    6.1.3 Bio Rad Laboratories Inc.
    6.1.4 Biokit SA
    6.1.5 bioMérieux SA
    6.1.6 F. Hoffmann-La Roche Ltd
    6.1.7 Ortho Clinical Diagnostics
    6.1.8 Siemens Healthcare GmbH
    6.1.9 Thermo Fisher Scientific
    6.1.10 ZEUS Scientific Inc.



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Global Quenching Oil 2019 Global Industry Analysis with Size, Share, Types, Applications, Growing Rate of Leading Companies Forecast to 2025

    Global Zinc Alloy Market 2019 Activities by Trend Analysis, Growth Status, Revenue Anticipation to 2023 | Research Report by Industry Research

    Acoustic Materials Market 2019 Offers Newest Industry Data, Industry Future Trends, Sales, Revenue, Growth Rate by Types and Applications Forecast till 2023

    Hepcidin Market 2019 Outlook by Import, Export, Consumption and Consumption Value by Major Countries and Key Players Forecast to 2023